MicroRNA-21 in Scleroderma Fibrosis and its Function in TGF-β- Regulated Fibrosis-Related Genes Expression
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-21 in Scleroderma Fibrosis and its Function in TGF-β- Regulated Fibrosis-Related Genes Expression
Authors
Keywords
Scleroderma, miR-21, Smad7, TGF-β
Journal
JOURNAL OF CLINICAL IMMUNOLOGY
Volume 33, Issue 6, Pages 1100-1109
Publisher
Springer Nature
Online
2013-05-08
DOI
10.1007/s10875-013-9896-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA Expression Abnormalities in Limited Cutaneous Scleroderma and Diffuse Cutaneous Scleroderma
- (2012) Honglin Zhu et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Bortezomib action in multiple myeloma: microRNA-mediated synergy (and miR-27a/CDK5 driven sensitivity)?
- (2012) E Ballabio et al. Blood Cancer Journal
- Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities
- (2011) Swati Bhattacharyya et al. Nature Reviews Rheumatology
- Proteasomal inhibition after injury prevents fibrosis by modulating TGF-β1signalling
- (2011) Gökhan M Mutlu et al. THORAX
- MicroRNA-29, a key regulator of collagen expression in systemic sclerosis
- (2010) Britta Maurer et al. ARTHRITIS AND RHEUMATISM
- Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension
- (2010) Eileen Hsu et al. ARTHRITIS AND RHEUMATISM
- Targeting MicroRNAs With Small Molecules: From Dream to Reality
- (2010) S Zhang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- On pediatric delirium and the use of the Pediatric Confusion Assessment Method for the Intensive Care Unit*
- (2010) Jan N. M. Schieveld CRITICAL CARE MEDICINE
- MicroRNAs and the regulation of fibrosis
- (2010) Xiaoying Jiang et al. FEBS Journal
- Circulating miR-29a levels in patients with scleroderma spectrum disorder
- (2010) Yoshio Kawashita et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
- (2010) Gang Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- MicroRNA array analysis of microRNAs related to systemic scleroderma
- (2010) Haitao Li et al. RHEUMATOLOGY INTERNATIONAL
- Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis
- (2009) Alfiya Akhmetshina et al. ARTHRITIS AND RHEUMATISM
- Transforming growth factor β as a therapeutic target in systemic sclerosis
- (2009) John Varga et al. Nature Reviews Rheumatology
- MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers
- (2009) M. Seike et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In VivoInvestigations on Anti-Fibrotic Potential of Proteasome Inhibition in Lung and Skin Fibrosis
- (2008) Serena Fineschi et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
- (2008) Thomas Thum et al. NATURE
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
- Small non-coding RNAs in animal development
- (2008) Giovanni Stefani et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
- (2008) E. van Rooij et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started